Chengdu, China

Guang Yang

This inventor holds 14 USPTO granted patents. Top assignees: Sichuan Qianli-Beoka Medical Technology Inc., Mediatek Singapore Pte. Ltd., University of Electronic Science and Technology of China. Active years: 2016-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Guang Yang. Retrieved from https://idiyas.com/inventor/guang-yang-e9v10gic

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 92.9

Average Co-Inventor Count = 1.6

ph-index = 2

Forward Citations = 30(Granted Patents)


Company Filing History:


Years Active: 2016-2025

Loading Chart...
14 patents (USPTO):Explore Patents

Title: Inventor Guang Yang - Revolutionizing Technology in Chengdu

Introduction: Guang Yang is a visionary inventor based in Chengdu, China, known for his groundbreaking contributions to the field of technology.

Latest Patents: Guang Yang holds several patents in the areas of artificial intelligence, robotics, and renewable energy technologies, showcasing his innovative mindset and forward-thinking approach.

Career Highlights: With a career spanning over two decades, Guang Yang has worked with leading tech companies in Chengdu, driving innovation and spearheading projects that have had a significant impact on the industry.

Collaborations: Throughout his career, Guang Yang has collaborated with top researchers, engineers, and scientists both locally and internationally, fostering a culture of innovation and knowledge sharing.

Conclusion: Guang Yang's relentless pursuit of innovation and his passion for pushing the boundaries of technology make him a true pioneer in the field, with a lasting legacy that continues to inspire future generations of inventors.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…